LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders (LSD-assist)
LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study
Sponsor: University Hospital, Basel, Switzerland
This PHASE2 trial investigates Anxiety Disorders and Patients and is currently completed. University Hospital, Basel, Switzerland leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2022 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Oct 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE2
▶ Show 6 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Apr 2019 — Apr 2020 [monthly]
Recruiting PHASE2
-
Jan 2019 — Apr 2019 [monthly]
Recruiting PHASE2
-
Jul 2018 — Jan 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .